Native Mineral Resources Holdings Limited
Native Mineral Resources Holdings Limited (NMR.AX) Financial Performance & Income Statement Overview
Analyze Native Mineral Resources Holdings Limited (NMR.AX) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Native Mineral Resources Holdings Limited (NMR.AX) Income Statement & Financial Overview
Review Native Mineral Resources Holdings Limited NMR.AX income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $3254.00 | $0.00 | $3638.00 | -$2690.00 |
| Cost of Revenue | $23664.00 | $19113.00 | $38228.00 | $22233.00 |
| Gross Profit | -$20410.00 | -$19113.00 | -$34590.00 | -$24923.00 |
| Gross Profit Ratio | -$6.27 | $0.00 | -$9.51 | $9.27 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.37M | $1.28M | $2.38M | $1.52M |
| Operating Expenses | $3.37M | $1.28M | $2.42M | $1.51M |
| Total Costs & Expenses | $3.37M | $1.29M | $2.42M | $1.54M |
| Interest Income | $0.00 | $6.00 | $1536.00 | $261.00 |
| Interest Expense | $0.00 | $29776.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $20410.00 | $19113.00 | $19114.00 | $22233.00 |
| EBITDA | -$3.37M | -$1.28M | -$4.79M | -$1.12M |
| EBITDA Ratio | -$1035.36 | $0.00 | -$1317.61 | $563.13 |
| Operating Income | -$3.37M | -$1.29M | -$2.40M | -$1.54M |
| Operating Income Ratio | -$1034.25 | $0.00 | -$659.59 | $571.39 |
| Other Income/Expenses (Net) | -$325617.00 | -$29929.00 | -$16274.00 | $399635.00 |
| Income Before Tax | -$3.69M | -$1.32M | -$2.42M | -$1.14M |
| Income Before Tax Ratio | -$1134.32 | $0.00 | -$664.06 | $422.83 |
| Income Tax Expense | $0.00 | $0.00 | -$8.00 | -$3.00 |
| Net Income | -$3.69M | -$1.32M | -$2.42M | -$1.14M |
| Net Income Ratio | -$1134.32 | $0.00 | -$664.06 | $422.83 |
| EPS | -$0.02 | -$0.006 | -$0.01 | -$0.009 |
| Diluted EPS | -$0.02 | -$0.006 | -$0.01 | -$0.009 |
| Weighted Avg Shares Outstanding | $197.50M | $209.85M | $184.42M | $132.17M |
| Weighted Avg Shares Outstanding (Diluted) | $197.49M | $209.85M | $185.29M | $132.17M |
The company's financials show resilient growth, with revenue advancing from -$2690.00 in Q4 2023 to $3254.00 in Q2 2025. Gross profit remained healthy with margins at -627% in Q2 2025 compared to 927% in Q4 2023. Operating income hit -$3.37M last quarter, sustaining a consistent -103425% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$3.37M. Net income dropped to -$3.69M, while earnings per share reached -$0.02. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan